Novaliq’s dry eye disease therapy receives US FDA approval
Pharmaceutical Technology
JUNE 9, 2023
It has been designed to address the unmet needs of patients and to provide quick action and well-tolerated dry eye drug therapy. Novaliq medical science and regulatory affairs vice-president Sonja Krösser stated: “We are proud that the FDA approved VEVYE.
Let's personalize your content